In Brief: Danninger Medical Technology
This article was originally published in The Gray Sheet
Danninger Medical Technology: Receives 510(k) clearance for the titanium version of its Synergy anterior spinal system. The device, currently available in stainless steel, is designed to correct deformities in the lumbar and thoracic regions of the spine. The Columbus, Ohio-based firm states that a 510(k) is pending for the Synergy titanium posterior spinal system...
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.